Country - Portugal
Summary - 1183/2024-Invitation To Submit A Proposal By Direct Adjustment For The Acquisition Of Cemiplimab [50 Mg/Ml; 7 Ml; Sun Inj; Frs], Dupilumab [200 Mg/1.14 Ml; Sun Inj; Syringe], Dupilumab [300 Mg/ 2 Ml; Sun I.
Deadline - login to view
MT reference number - 99918153
Product classification - Pharmaceutical products
Address - Portugal
Contact details - 565656565
Tender notice no. - 76454545
MT Ref Id - 99918153
Document Type - Tender Notices
Description - Description: INVITATION TO SUBMIT A PROPOSAL BY DIRECT ADJUSTMENT FOR THE ACQUISITION OF CEMIPLIMAB [50 MG/ML; 7 ML; SOL INJ; FRS], DUPILUMAB [200 MG/1.14 ML; SOL INJ; SYRINGE], DUPILUMAB [300 MG/ 2 ML; SOL INJ; PEN1183/2024-INVITATION TO SUBMIT A PR OPOSAL BY DIRECT ADJUSTMENT FOR THE ACQUISITION OF CEMIPLIMAB [50 MG/ML; 7 ML; SOL INJ; FRS], DUPILUMAB [200 MG/1.14 ML; SOL INJ; SYRINGE], DUPILUMAB [300 MG/ 2 ML; SOL INJ; PEN/SYRINGE], DUPILUMAB [200 MG/1.14 ML; SOL INJ; PEN], MILRINONE [10 MG/10 ML; SOL INJ; F/AMP], RASBURICASE [1.5 MG/ML; 5 ML; CONC POWDER SOL INJ; FRS], RASBURICASE [1.5 MG/ML; 1 ML; CONC POWDER SOL INJ; FRS], THYROTROPIN [0.9 MG; F/AMP] AND VANDETANIB [100 MG; CAP/COMP] TO
Mt Ref Id - 99918153
Deadline - Nov 30, -0001
Similar Tenders :
Healthcare and Medicine